Effects of TDCS and Physical Therapy in Chronic Migraine
Launched by FEDERAL UNIVERSITY OF PARAÍBA · Jan 20, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how two different treatments—transcranial Direct Current Stimulation (tDCS) and physical therapy—can help reduce the pain and frequency of chronic migraines in women. The study will involve women aged 18 to 50 who have been diagnosed with chronic migraines. Participants will be placed into one of four groups to see how each treatment affects their migraine symptoms.
To be part of this study, women need to be between 18 and 50 years old, literate, and have chronic migraines. They should not be using a lot of headache medications or receiving any other treatments for their migraines. Participants can expect to be monitored closely and will receive either tDCS, physical therapy, or both to see which method works best for them. It’s important to note that women who are pregnant, have certain health conditions, or have recently changed their migraine medication will not be eligible to join the trial.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women;
- • 18-50 years old;
- • with Chronic Migraine according to ICHD-3 beta;
- • literate;
- • stable on routine medications specific for MC for at least 2 months, who were not undergoing other types of non-pharmacological interventions for MC, not lactating or pregnant, without neurological diseases or serious neuropsychiatric diseases, without other types of associated headaches, without signs and/or symptoms of spinal radiculopathy, without metal implants located in the head and/or cochlear implants.
- Exclusion Criteria:
- • who perhaps become pregnant during the execution of the clinical trial
- • present some disease that disables their continuity in the treatment
- • start another type of treatment
- • show changes in physical activity and/or eating routine during the research
- • has severe depression (BDI \> 35).
About Federal University Of Paraíba
The Federal University of Paraíba (UFPB) is a renowned academic institution located in Brazil, dedicated to advancing education, research, and innovation in various fields, including health sciences. With a commitment to excellence, UFPB actively engages in clinical trials aimed at contributing to medical knowledge and improving patient care. The university's research initiatives are supported by a multidisciplinary team of experts who collaborate to ensure rigorous ethical standards and scientific validity in their studies. UFPB's clinical trials focus on addressing pressing health challenges, fostering partnerships within the scientific community, and translating research findings into practical applications for the benefit of society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
João Pessoa, Paraiba, Brazil
Patients applied
Trial Officials
Renata Aranha
Principal Investigator
Federal University of Paraiba
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials